Literature DB >> 32334847

Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context.

A Daruich1, D Martin2, D Bremond-Gignac3.   

Abstract

We report here the case of a 27-year-old man who consulted by telemedicine during the Coronavirus disease 2019 (COVID-19) pandemic, due to foreign body sensation and left eye redness. Examination revealed unilateral eyelid edema and moderate conjunctival hyperemia. A few hours later, the patient experienced intense headache and developed fever, cough and severe dyspnea. A nasopharyngeal swab proved positive for SARS-CoV-2. This case demonstrates that conjunctivitis can be the inaugural manifestation of the COVID-19 infection. It illustrates the interest of telemedicine in ophthalmology during the COVID-19 pandemic, since moderate conjunctival hyperemia can be the first sign of a severe respiratory distress.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  COVID-19; Conjonctivite; Conjunctivitis; Eye; Manifestation oculaire; Ocular; Ophtalmologie; Ophthalmology; SARS-CoV-2; SRAS-CoV-2; Telemedicine; Télémédecine

Mesh:

Year:  2020        PMID: 32334847      PMCID: PMC7164841          DOI: 10.1016/j.jfo.2020.04.002

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


Introduction

Since the Coronavirus Disease 2019 (COVID-19) emergence on December 2019 in Wuhan, China, there have been anecdotal reports of ocular manifestations in patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. In a large study including 1099 hospitalised patients with laboratory-confirmed COVID-19 from 30 hospitals in China, conjunctival congestion was documented in 9 patients (0.8%) [2]. In a report of 38 hospitalised patients diagnosed clinically as COVID-19, one third had ocular abnormalities, including conjunctival hyperemia, chemosis, epiphora, and increased secretions [3]. Ocular manifestations were mostly reported during the middle phase of the disease, and in patients with severe pneumonia [3]. More severe ocular manifestations as anterior uveitis, retinitis, and optic neuritis have been only documented in animal models [4]. Telemedicine has been implemented worldwide in response of COVID-19 pandemic to bring medical care to patients while attempting to reduce the transmission of SARS-CoV-2 to patients, families, and healthcare staff [5], [6], [7]. We present here the case of an otherwise healthy patient who consulted by telemedicine for ocular manifestations, and presented shortly thereafter a PCR-proven COVID-19.

Case presentation

A 27-year-old man consulted his ophthalmologist by telemedicine in Argentina during Coronavirus Disease 2019 (COVID-19) pandemic, because of foreign body sensation and red left eye. The patient did not present epiphora, secretion or decreased vision. There were no systemic symptoms. Personal history was unremarkable and he was a non-smoker sportsman. External examination revealed unilateral eyelid edema and moderate conjunctival hyperemia (Fig. 1 ). A topical association of antibiotic and corticoids was prescribed. Three hours later, the patient presented severe headache and fever at 39 °C and he developed 12 hours later a cough and severe dyspnea impairing speech. RT-PCR from nasopharyngeal swabs resulted positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Eleven days later, a second consultation by telemedicine showed that ocular signs had resolved. Dyspnea and cough were less severe but still present.
Figure 1

Smartphone photograph of a left eye conjunctivitis as first presentation of Coronavirus Disease 2019 during teleophthalmology consultation. A. Left eyelid edema. B. Moderate temporal conjunctival hyperemia of the left eye. C. Inferior bulbar conjunctival hyperemia of the left eye.

Smartphone photograph of a left eye conjunctivitis as first presentation of Coronavirus Disease 2019 during teleophthalmology consultation. A. Left eyelid edema. B. Moderate temporal conjunctival hyperemia of the left eye. C. Inferior bulbar conjunctival hyperemia of the left eye.

Discussion

We present here a case that illustrates the interest of telemedicine in an ophthalmological setting during the COVID-19 pandemic, where moderate conjunctival hyperemia was the presenting sign of the infection that rapidly progressed to respiratory distress. Ocular anomalies, including acute follicular conjunctivitis [8], conjunctival hyperemia, chemosis, epiphora, and increased secretions have been reported in patients with COVID-19 [3]. These manifestations have been observed to occur more frequently in patients with severe pneumonia and during the middle phase of illness [3] with only 1 patient in a series of 38 cases presenting with conjunctivitis as the initial manifestation of the disease [3]. Interestingly, in the present case, ocular symptoms were the first manifestation of the disease that progressed within a few hours to a severe respiratory distress. Here, the patient presented unilateral manifestations, but bilateral follicular conjunctivitis has been also reported in a COVID-19 patient [8]. Additionally, only 5% of conjunctival swabs from patients with ocular manifestations have proven positive for SARS-CoV-2 [3], possibly indicating a low prevalence of the virus in conjunctival secretions and tears [1]. Alternatively, the virus could be present at the ocular surface, but with viral loads below the detection thresholds of existing PCR diagnosis techniques. Interestingly, our patient did not experience epiphora or secretions. Vision loss has not been reported among the ocular manifestations of COVID-19 [3], [8], which is in accordance with the case presented here. This case also illustrates the usefulness and relevance of teleophthalmology procedures during the COVID-19 epidemics, which, in addition to preventing the transmission of SARS-CoV-2, could help detect potentially COVID-19 patients. Ophthalmologists should be aware of these unusual ocular presentations of COVID-19 since they could precede the development of severe respiratory distress.

Disclosure of interest

The authors declare that they have no competing interest.
  7 in total

1.  Virtually Perfect? Telemedicine for Covid-19.

Authors:  Judd E Hollander; Brendan G Carr
Journal:  N Engl J Med       Date:  2020-03-11       Impact factor: 91.245

2.  Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection.

Authors:  Jianhua Xia; Jianping Tong; Mengyun Liu; Ye Shen; Dongyu Guo
Journal:  J Med Virol       Date:  2020-03-12       Impact factor: 2.327

3.  Telemedicine in the Time of Coronavirus.

Authors:  Brook Calton; Nauzley Abedini; Michael Fratkin
Journal:  J Pain Symptom Manage       Date:  2020-03-31       Impact factor: 3.612

4.  Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease.

Authors:  Lu Chen; Meizhou Liu; Lei Liu; Guoming Zhang; Jiantao Wang; Zheng Zhang; Kun Qiao; Ting Huang; Miaohong Chen; Na Xin; Zuliang Huang
Journal:  Br J Ophthalmol       Date:  2020-04-07       Impact factor: 4.638

Review 5.  Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals.

Authors:  Ivan Seah; Rupesh Agrawal
Journal:  Ocul Immunol Inflamm       Date:  2020-03-16       Impact factor: 3.070

6.  Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.

Authors:  Ping Wu; Fang Duan; Chunhua Luo; Qiang Liu; Xingguang Qu; Liang Liang; Kaili Wu
Journal:  JAMA Ophthalmol       Date:  2020-05-01       Impact factor: 7.389

7.  Telemedicine in the Era of COVID-19.

Authors:  Jay Portnoy; Morgan Waller; Tania Elliott
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-24
  7 in total
  28 in total

1.  The Association of Clinical Symptoms and Coexistent Clinical Conditions with Ophthalmic Manifesting in COVID-19 Patients.

Authors:  Mansour Babaei; Masomeh Bayani; Maral Farzin; Seyed Ahmad Rasoulinejad
Journal:  Caspian J Intern Med       Date:  2022

Review 2.  A Review of Neuro-Ophthalmological Manifestations of Human Coronavirus Infection.

Authors:  Maria Elisa Luís; Diogo Hipólito-Fernandes; Catarina Mota; Diogo Maleita; Catarina Xavier; Tiago Maio; João Paulo Cunha; Joana Tavares Ferreira
Journal:  Eye Brain       Date:  2020-10-30

3.  Retinal findings in patients with COVID-19: Results from the SERPICO-19 study.

Authors:  Alessandro Invernizzi; Alessandro Torre; Salvatore Parrulli; Federico Zicarelli; Marco Schiuma; Valeria Colombo; Andrea Giacomelli; Mario Cigada; Laura Milazzo; Annalisa Ridolfo; Ivano Faggion; Laura Cordier; Marta Oldani; Sara Marini; Paolo Villa; Giuliano Rizzardini; Massimo Galli; Spinello Antinori; Giovanni Staurenghi; Luca Meroni
Journal:  EClinicalMedicine       Date:  2020-09-20

Review 4.  [Ophthalmological care of SARS-CoV-2 positive patients in intensive care units].

Authors:  Luisa Schwarz; Christoph Lwowski; Ingo Schmack; Michael Müller; Elisabeth Adam; Kai Zacharowski; Thomas Kohnen
Journal:  Ophthalmologe       Date:  2020-07       Impact factor: 1.059

Review 5.  Ocular Involvement in Coronavirus Disease 2019: Up-to-Date Information on Its Manifestation, Testing, Transmission, and Prevention.

Authors:  Ziyan Chen; Gang Yuan; Fang Duan; Kaili Wu
Journal:  Front Med (Lausanne)       Date:  2020-11-30

6.  The evolution of the changes in the clinical course: a multicenter survey-related impression of the ophthalmologists at the peak of the COVID-19 pandemic in Turkey.

Authors:  Burak Erdem; Mustafa Gok; Sedat Bostan
Journal:  Int Ophthalmol       Date:  2021-01-02       Impact factor: 2.031

Review 7.  COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge.

Authors:  Jacek Baj; Hanna Karakuła-Juchnowicz; Grzegorz Teresiński; Grzegorz Buszewicz; Marzanna Ciesielka; Ryszard Sitarz; Alicja Forma; Kaja Karakuła; Wojciech Flieger; Piero Portincasa; Ryszard Maciejewski
Journal:  J Clin Med       Date:  2020-06-05       Impact factor: 4.241

8.  Clinical and Prodromal Ocular Symptoms in Coronavirus Disease: A Systematic Review and Meta-Analysis.

Authors:  Takenori Inomata; Koji Kitazawa; Toshiki Kuno; Jaemyoung Sung; Masahiro Nakamura; Masao Iwagami; Hisato Takagi; Akie Midorikawa-Inomata; Jun Zhu; Keiichi Fujimoto; Yuichi Okumura; Maria Miura; Kenta Fujio; Kunihiko Hirosawa; Yasutsugu Akasaki; Mizu Kuwahara; Reza Dana; Akira Murakami
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

9.  COVID-19 and the eye.

Authors:  John G Lawrenson; Roger J Buckley
Journal:  Ophthalmic Physiol Opt       Date:  2020-07-06       Impact factor: 3.992

Review 10.  How to deal with coronavirus disease 2019: A comprehensive narrative review about oral involvement of the disease.

Authors:  Giorgia Capocasale; Riccardo Nocini; Paolo Faccioni; Dario Donadello; Dario Bertossi; Massimo Albanese; Francesca Zotti
Journal:  Clin Exp Dent Res       Date:  2020-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.